"Shock" publishes high-impact, original peer-reviewed studies and reviews focused on basic, translational, and clinical research on shock, injury, inflammation, and sepsis. The journal serves as a vital platform for disseminating knowledge and advancements in understanding the complex pathophysiology of these critical conditions. It provides insights into novel diagnostic and therapeutic strategies, contributing to improved patient outcomes.
"Shock" covers a broad scope of topics, including molecular mechanisms of cellular injury, immune responses, organ dysfunction, and the development of innovative treatment approaches. The journal facilitates the exchange of ideas and collaboration among researchers and clinicians in diverse fields such as trauma surgery, critical care medicine, immunology, and molecular biology. It is indexed in major biomedical databases.
By promoting the highest standards of scientific rigor and clinical relevance, "Shock" aims to drive innovation and inform clinical practice in the management of shock, injury, and sepsis. Researchers are encouraged to submit their groundbreaking work, furthering the journal's mission of advancing the understanding and treatment of these life-threatening conditions.